|
1F9E
CASPASE-8 SPECIFICITY PROBED AT SUBSITE S4: CRYSTAL STRUCTURE OF THE CASPASE-8-Z-DEVD-CHO
Deposited 2000-07-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
222–374(153 aa)
Chain B
390–478(89 aa)
Chain C
222–374(153 aa)
Chain D
390–478(89 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;1-propanol, sodium citrate, MES
, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 4.0K, temperature 277K
|
Resolution 2.90 Å
R-free 0.289
|
|
1F9E
CASPASE-8 SPECIFICITY PROBED AT SUBSITE S4: CRYSTAL STRUCTURE OF THE CASPASE-8-Z-DEVD-CHO
Deposited 2000-07-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain E
222–374(153 aa)
Chain F
390–478(89 aa)
Chain G
222–374(153 aa)
Chain H
390–478(89 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;1-propanol, sodium citrate, MES
, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 4.0K, temperature 277K
|
Resolution 2.90 Å
R-free 0.289
|
|
1F9E
CASPASE-8 SPECIFICITY PROBED AT SUBSITE S4: CRYSTAL STRUCTURE OF THE CASPASE-8-Z-DEVD-CHO
Deposited 2000-07-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain I
222–374(153 aa)
Chain J
390–478(89 aa)
Chain K
222–374(153 aa)
Chain L
390–478(89 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;1-propanol, sodium citrate, MES
, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 4.0K, temperature 277K
|
Resolution 2.90 Å
R-free 0.289
|
|
1I4E
CRYSTAL STRUCTURE OF THE CASPASE-8/P35 COMPLEX
Deposited 2001-02-20
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
222–479(258 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;VAPOR DIFFUSION, HANGING DROP
|
Resolution 3.00 Å
R-free 0.296
|
|
1I4E
CRYSTAL STRUCTURE OF THE CASPASE-8/P35 COMPLEX
Deposited 2001-02-20
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
222–479(258 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;VAPOR DIFFUSION, HANGING DROP
|
Resolution 3.00 Å
R-free 0.296
|
|
1QDU
CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TRIPEPTIDE KETONE INHIBITOR ZEVD-DCBMK
Deposited 1999-07-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
222–374(153 aa)
Chain B
390–477(88 aa)
Chain C
222–374(153 aa)
Chain D
390–477(88 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.3;277 K;300mM ammonium phosphate, 27% (w/v) isopropanol, 100mM sodium phosphate, pH 6.3, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.80 Å
R-free 0.302
|
|
1QDU
CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TRIPEPTIDE KETONE INHIBITOR ZEVD-DCBMK
Deposited 1999-07-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain E
222–374(153 aa)
Chain F
390–477(88 aa)
Chain G
222–374(153 aa)
Chain H
390–477(88 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.3;277 K;300mM ammonium phosphate, 27% (w/v) isopropanol, 100mM sodium phosphate, pH 6.3, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.80 Å
R-free 0.302
|
|
1QDU
CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TRIPEPTIDE KETONE INHIBITOR ZEVD-DCBMK
Deposited 1999-07-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain I
222–374(153 aa)
Chain J
390–477(88 aa)
Chain K
222–374(153 aa)
Chain L
390–477(88 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.3;277 K;300mM ammonium phosphate, 27% (w/v) isopropanol, 100mM sodium phosphate, pH 6.3, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.80 Å
R-free 0.302
|
|
1QTN
CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TETRAPEPTIDE INHIBITOR ACE-IETD-ALDEHYDE
Deposited 1999-06-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
223–374(152 aa)
Fragment:P18 FRAGMENT
Chain B
390–479(90 aa)
Fragment:P11 FRAGMENT
|
Not recorded
|
DTD DITHIANE DIOL × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;282 K;3 MICROLITERS PROTEIN (8.4 MG/ ML IN 20 MM TRISHCL, 100MM DTT AT PH 8.0) MIXED
WITH 3 MICROLITERS WELL BUFFER (1.4 SODIUM CITRATE, 0.1M HEPES, AT PH 8.0) AT
4 DEG. C, VAPOR DIFFUSION, SITTING DROP, temperature 282K
|
Resolution 1.20 Å
R-free 0.188
|
|
2C2Z
Crystal structure of caspase-8 in complex with aza-peptide Michael acceptor inhibitor
Deposited 2005-10-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
218–374(157 aa)
Fragment:ALPHA SUB-UNIT, RESIDUES 218-374
Chain B
376–479(104 aa)
Fragment:BETA-SUBUNIT, RESIDUES 376-479
|
Not recorded
|
DTD DITHIANE DIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;1.4M SODIUM CITRATE, 100MM HEPES PH 8.0
|
Resolution 1.95 Å
R-free 0.187
|
|
2FUN
alternative p35-caspase-8 complex
Deposited 2006-01-27
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
222–479(258 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;295 K;VAPOR DIFFUSION, HANGING DROP, pH 7, temperature 295K
|
Resolution 3.00 Å
R-free 0.260
|
|
2FUN
alternative p35-caspase-8 complex
Deposited 2006-01-27
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
222–479(258 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;295 K;VAPOR DIFFUSION, HANGING DROP, pH 7, temperature 295K
|
Resolution 3.00 Å
R-free 0.260
|
|
2K7Z
Solution Structure of the Catalytic Domain of Procaspase-8
Deposited 2008-08-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
217–479(263 aa)
Fragment:UNP residues 213-479
|
Mutation:C360A
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 8;305 K;Ionic strength (raw mmCIF value) 0.1;Pressure ambient
NMR sample composition
0.8 mM [U-99% 13C; U-99% 15N] procaspase8, 10 mM DTT,
100 mM sodium chloride, 20 mM [U-2H] TRIS, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.8 mM [U-100% 13C; U-100% 15N; 80% 2H] procaspase8, 10 mM DTT,
100 mM sodium chloride, 20 mM [U-2H] TRIS, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
2Y1L
Caspase-8 in Complex with DARPin-8.4
Deposited 2010-12-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 7
PDB declaration: octameric
|
Chain A
217–374(158 aa)
Fragment:P18 SUBUNIT, RESIDUES 218-374
Chain B
376–479(104 aa)
Fragment:P10 SUBUNIT, RESIDUES 376-479
Chain C
217–374(158 aa)
Fragment:P18 SUBUNIT, RESIDUES 218-374
Chain D
376–479(104 aa)
Fragment:P10 SUBUNIT, RESIDUES 376-479
|
Not recorded
|
SO4 SULFATE ION × 3
EDO 1,2-ETHANEDIOL × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.8;100 MM CITRIC ACID PH 4.9 (RT), 200 MM LI2SO4, 22.5% PEG 4K.
|
Resolution 1.80 Å
R-free 0.218
|
|
3H11
Zymogen caspase-8:c-FLIPL protease domain complex
Deposited 2009-04-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
217–479(263 aa)
|
Mutation:D359A, D369A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 10.5;293 K;0.9 M sodium dihydrogen phosphate, 0.8 M dipotassium hydrogen phosphate, 0.1 M N-cyclohexyl-3-aminopropanesulfonic acid (CAPS), 0.2 M lithium sulfate, pH 10.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 1.90 Å
R-free 0.250
|
|
3KJN
Caspase 8 bound to a covalent inhibitor
Deposited 2009-11-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain A
211–374(164 aa)
Fragment:residues 211-374
Chain B
385–479(95 aa)
Fragment:residues 385-479
|
Not recorded
|
DTT 2,3-DIHYDROXY-1,4-DITHIOBUTANE × 2
B93 (3S)-3-({[(5S)-2-{2-[(1H-benzimidazol-5-ylcarbonyl)amino]ethyl}-7-(cyclohexylmethyl)-1,3-dioxo-2,3,5,8-tetrahydro-1H-[1,2,4]triazolo[1,2-a]pyridazin-5-yl]carbonyl}amino)-4-oxopentanoic acid × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.5;277 K;2 microliters of 100 mM inhibitor stock in DMSO was added to 100 microliters of 8.4 mg/mL protein in 20 mM Tris, 100 mM DTT, pH 8.0. Protein solution was mixed with an equal volume of well solution (1.0-1.1 M Citrate, 50 mM HEPES or PIPES pH 6.5, 25 mM DTT), VAPOR DIFFUSION, temperature 277K
|
Resolution 1.80 Å
R-free 0.202
|
|
3KJQ
Caspase 8 with covalent inhibitor
Deposited 2009-11-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain A
211–374(164 aa)
Chain B
385–479(95 aa)
|
Not recorded
|
B94 (3S)-3-({[(5S,8R)-2-(3-carboxypropyl)-8-(2-{[(4-chlorophenyl)acetyl]amino}ethyl)-1,3-dioxo-2,3,5,8-tetrahydro-1H-[1,2,4]triazolo[1,2-a]pyridazin-5-yl]carbonyl}amino)-4-oxopentanoic acid × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.8;277 K;2 microliters of 100 mM inhibitor stock in DMSO was added to 100 microliters of 8.4 mg/mL protein in 20 mM Tris, 100 mM DTT, pH 8.0. Protein solution was mixed with an equal volume of well solution (1.0-1.1 M Citrate, 50 mM HEPES or PIPES pH 6.5, 25 mM DTT), VAPOR DIFFUSION, temperature 277K
|
Resolution 1.80 Å
R-free 0.207
|
|
4JJ7
Caspase-3 specific unnatural amino acid-based peptides
Deposited 2013-03-07
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
217–479(263 aa)
|
Not recorded
|
DTD DITHIANE DIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;295 K;1 M Sodium citrate, 0.1M HEPES pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
Resolution 1.18 Å
R-free 0.157
|
|
4PRZ
Caspase-8 specific unnatural amino acid peptides
Deposited 2014-03-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
217–479(263 aa)
Fragment:UNP RESIDUES 217-479
|
Not recorded
|
DTD DITHIANE DIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.4;295 K;1.0 M sodium citrate, 0.1 M HEPES, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
Resolution 2.12 Å
R-free 0.218
|
|
4PS1
Caspase-8 specific unnatural amino acid peptides
Deposited 2014-03-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
217–479(263 aa)
Fragment:UNP RESIDUES 217-479
|
Not recorded
|
DTT 2,3-DIHYDROXY-1,4-DITHIOBUTANE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;295 K;0.1 M Sodium citrate, pH 5.5, 36% PEG600, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
Resolution 1.73 Å
R-free 0.185
|
|
4PS1
Caspase-8 specific unnatural amino acid peptides
Deposited 2014-03-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
217–479(263 aa)
Fragment:UNP RESIDUES 217-479
|
Not recorded
|
DTT 2,3-DIHYDROXY-1,4-DITHIOBUTANE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;295 K;0.1 M Sodium citrate, pH 5.5, 36% PEG600, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
Resolution 1.73 Å
R-free 0.185
|
|
4PS1
Caspase-8 specific unnatural amino acid peptides
Deposited 2014-03-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
217–479(263 aa)
Fragment:UNP RESIDUES 217-479
|
Not recorded
|
DTT 2,3-DIHYDROXY-1,4-DITHIOBUTANE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;295 K;0.1 M Sodium citrate, pH 5.5, 36% PEG600, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
Resolution 1.73 Å
R-free 0.185
|
|
4PS1
Caspase-8 specific unnatural amino acid peptides
Deposited 2014-03-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
217–479(263 aa)
Fragment:UNP RESIDUES 217-479
|
Not recorded
|
DTT 2,3-DIHYDROXY-1,4-DITHIOBUTANE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;295 K;0.1 M Sodium citrate, pH 5.5, 36% PEG600, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
Resolution 1.73 Å
R-free 0.185
|
|
4ZBW
Crystal structure of death effector domain of Caspase8 in Homo Sapiens
Deposited 2015-04-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
61–247(187 aa)
Chain B
61–247(187 aa)
|
Mutation:F122A, I128D
Mutation:F122A, I128D
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;pH 8.5;293 K;0.2M sodium chloride, 25% PEG3350
|
Resolution 2.20 Å
R-free 0.251
|
|
5H31
Structural basis for dimerization of the death effector domains of Caspase-8
Deposited 2016-10-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–188(188 aa)
Fragment:UNP residues 1-188
Chain B
1–188(188 aa)
Fragment:UNP residues 1-188
|
Mutation:F122A
Mutation:F122A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;pH 8.5;293 K;100 mM sodium chloride, 100 mM Tris, 21% PEG3350, 10 mM Sarcosine,
|
Resolution 3.17 Å
R-free 0.268
|
|
5H31
Structural basis for dimerization of the death effector domains of Caspase-8
Deposited 2016-10-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain C
1–188(188 aa)
Fragment:UNP residues 1-188
Chain D
1–188(188 aa)
Fragment:UNP residues 1-188
|
Mutation:F122A
Mutation:F122A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;pH 8.5;293 K;100 mM sodium chloride, 100 mM Tris, 21% PEG3350, 10 mM Sarcosine,
|
Resolution 3.17 Å
R-free 0.268
|
|
5H33
Structural basis for dimerization of the death effector domains of Caspase-8
Deposited 2016-10-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–188(188 aa)
Chain B
1–188(188 aa)
|
Mutation:F122A
Mutation:F122A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;pH 8.5;293 K;50mM sodium chloride, 100mM Tris pH 8.5, 22.5% PEG3350
|
Resolution 3.60 Å
R-free 0.313
|
|
5L08
Cryo-EM structure of Casp-8 tDED filament
Deposited 2016-07-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 9
PDB declaration: nonameric
|
Chain A
60–243(184 aa)
Chain B
60–243(184 aa)
Chain C
60–243(184 aa)
Chain D
60–243(184 aa)
Chain E
60–243(184 aa)
Chain F
60–243(184 aa)
Chain G
60–243(184 aa)
Chain H
60–243(184 aa)
Chain I
60–243(184 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.60 Å
|
|
6AGW
Pro-domain of Caspase-8
Deposited 2018-08-15
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–180(180 aa)
Fragment:UNP residues 1-180
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;(NH4)2SO4, Cacodylate, NaCl
|
Resolution 2.09 Å
R-free 0.269
|
|
6PX9
Crystal structure of procaspase-8 in complex with covalent small molecule inhibitor 63-R
Deposited 2019-07-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
276–538(263 aa)
Fragment:UNP residues 276-538
Chain B
276–538(263 aa)
Fragment:UNP residues 276-538
|
Mutation:D374A, D384A, C409S, C433S
Mutation:D374A, D384A, C409S, C433S
|
63R N-{(3R)-1-[4-(morpholin-4-yl)benzene-1-carbonyl]piperidin-3-yl}-N-phenylacetamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;0.1 M imidazole, pH 8.0, 1.0 M sodium citrate
|
Resolution 2.88 Å
R-free 0.366
|
|
6PX9
Crystal structure of procaspase-8 in complex with covalent small molecule inhibitor 63-R
Deposited 2019-07-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain C
276–538(263 aa)
Fragment:UNP residues 276-538
Chain D
276–538(263 aa)
Fragment:UNP residues 276-538
|
Mutation:D374A, D384A, C409S, C433S
Mutation:D374A, D384A, C409S, C433S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;0.1 M imidazole, pH 8.0, 1.0 M sodium citrate
|
Resolution 2.88 Å
R-free 0.366
|
|
6PX9
Crystal structure of procaspase-8 in complex with covalent small molecule inhibitor 63-R
Deposited 2019-07-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain E
276–538(263 aa)
Fragment:UNP residues 276-538
Chain F
276–538(263 aa)
Fragment:UNP residues 276-538
|
Mutation:D374A, D384A, C409S, C433S
Mutation:D374A, D384A, C409S, C433S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;0.1 M imidazole, pH 8.0, 1.0 M sodium citrate
|
Resolution 2.88 Å
R-free 0.366
|
|
6X8H
Caspase-8 in complex with AOMK inhibitor, Ac-DW3-KE, forms tetrahedral adduct
Deposited 2020-06-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
276–443(168 aa)
Fragment:p18 (UNP residues 276-443)
Chain B
444–538(95 aa)
Fragment:p10 (UNP residues 444-538)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.1;295 K;1:1 protein : 0.10 M HEPES, 1.0 M sodium citrate
|
Resolution 1.48 Å
R-free 0.167
|
|
7LVM
CASP8 isoform B DED domain
Deposited 2021-02-25
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–188(187 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;294 K;100mM Hepes pH 7.5, 20% Ethylene Glycol, 18% PEG 3350, 200mM Sodium Chloride
|
Resolution 1.47 Å
R-free 0.233
|
|
8YBX
Structure of the FADD/Caspase-8/cFLIP death effector domain assembly
Deposited 2024-02-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 10
PDB declaration: decameric
|
Chain A
1–479(479 aa)
Chain B
1–479(479 aa)
Chain C
1–479(479 aa)
|
Mutation:F122G/L123G, C360A, D374A, D384A
Mutation:F122G/L123G, C360A, D374A, D384A
Mutation:F122G/L123G, C360A, D374A, D384A
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.68 Å
|
|
8YD7
Structure of FADD/Caspase-8/cFLIP death effector domain assembly
Deposited 2024-02-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 10
PDB declaration: decameric
|
Chain A
1–185(185 aa)
Chain B
1–185(185 aa)
Chain C
1–185(185 aa)
Chain D
1–185(185 aa)
Chain E
1–185(185 aa)
|
Mutation:F122G,L123G
Non-standard monomer:Yes (specific site not provided by mmCIF)
Mutation:F122G,L123G
Non-standard monomer:Yes (specific site not provided by mmCIF)
Mutation:F122G,L123G
Non-standard monomer:Yes (specific site not provided by mmCIF)
Mutation:F122G,L123G
Non-standard monomer:Yes (specific site not provided by mmCIF)
Mutation:F122G,L123G
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
SE SELENIUM ATOM × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;HEPES, TBG, PEG8000, TCEP, sodium chloride
|
Resolution 3.32 Å
R-free 0.231
|
|
8YD8
Structure of FADD/Caspase-8/cFLIP death effector domain assembly
Deposited 2024-02-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 10
PDB declaration: decameric
|
Chain A
1–185(185 aa)
Chain B
1–185(185 aa)
Chain C
1–185(185 aa)
Chain D
1–185(185 aa)
Chain E
1–185(185 aa)
|
Mutation:F122G, L123G
Mutation:F122G, L123G
Mutation:F122G, L123G
Mutation:F122G, L123G
Mutation:F122G, L123G
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;HEPES, PEG 8000, TBG, TCEP, sodium chloride
|
Resolution 3.11 Å
R-free 0.241
|
|
8YM4
Structure of Caspase-8/cFLIP death effector domain assembly
Deposited 2024-03-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 10
PDB declaration: decameric
|
Chain A
1–185(185 aa)
Chain B
1–185(185 aa)
Chain C
1–185(185 aa)
Chain D
1–185(185 aa)
|
Mutation:F122G, L123G
Non-standard monomer:Yes (specific site not provided by mmCIF)
Mutation:F122G, L123G
Non-standard monomer:Yes (specific site not provided by mmCIF)
Mutation:F122G, L123G
Non-standard monomer:Yes (specific site not provided by mmCIF)
Mutation:F122G, L123G
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
SE SELENIUM ATOM × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;0.1 M MES pH 6.5, 0.08 M sodium chloride, 0.2 M Potassium Thiocyanate, 10 % PEG 4000, 0.01 M TCEP
|
Resolution 2.34 Å
R-free 0.253
|
|
8YM5
Structure of Caspase-8/cFLIP death effector domain assembly
Deposited 2024-03-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 10
PDB declaration: decameric
|
Chain A
1–185(185 aa)
Chain B
1–185(185 aa)
Chain C
1–185(185 aa)
Chain D
1–185(185 aa)
|
Mutation:F122G, L123G
Non-standard monomer:Yes (specific site not provided by mmCIF)
Mutation:F122G, L123G
Non-standard monomer:Yes (specific site not provided by mmCIF)
Mutation:F122G, L123G
Non-standard monomer:Yes (specific site not provided by mmCIF)
Mutation:F122G, L123G
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;0.1 M MES pH 6.5, 0.08 M sodium chloride, 0.2 M Potassium Thiocyanate, 10 % PEG 4000, 0.01 M TCEP
|
Resolution 2.09 Å
R-free 0.231
|
|
8YM6
Structure of Caspase-8/cFLIP death effector domain assembly
Deposited 2024-03-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 13
PDB declaration: tridecameric
|
Chain A
1–185(185 aa)
Chain B
1–185(185 aa)
Chain C
1–185(185 aa)
Chain D
1–185(185 aa)
|
Mutation:F122G, L123G
Mutation:F122G, L123G
Mutation:F122G, L123G
Mutation:F122G, L123G
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;0.1 M HEPES pH 7.5, 0.2 M Lithium chloride, 20 % PEG 400, 0.1 M TBG pH 9.0
|
Resolution 3.30 Å
R-free 0.264
|
|
8YNI
Structure of the FADD/Caspase-8/cFLIP death effector domain assembly
Deposited 2024-03-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 11
PDB declaration: 11-meric
|
Chain A
1–479(479 aa)
Chain B
1–479(479 aa)
Chain C
1–479(479 aa)
|
Mutation:F122G, L123G, C360A, D374A, D384A
Mutation:F122G, L123G, C360A, D374A, D384A
Mutation:F122G, L123G, C360A, D374A, D384A
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.66 Å
|
|
8YNK
Structure of the Caspase-8/cFLIP death effector domain assembly
Deposited 2024-03-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain A
1–479(479 aa)
Chain B
1–479(479 aa)
Chain C
1–479(479 aa)
|
Mutation:F122G, L123G, C360A, D374A, D384A
Mutation:F122G, L123G, C360A, D374A, D384A
Mutation:F122G, L123G, C360A, D374A, D384A
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.62 Å
|
|
8YNL
Structure of the Caspase-8/cFLIP death effector domain assembly
Deposited 2024-03-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 9
PDB declaration: nonameric
|
Chain A
1–479(479 aa)
Chain B
1–479(479 aa)
Chain C
1–479(479 aa)
|
Mutation:F122G, L123G, C360A, D374A, D384A
Mutation:F122G, L123G, C360A, D374A, D384A
Mutation:F122G, L123G, C360A, D374A, D384A
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.55 Å
|
|
8YNM
Structure of the Caspase-8/cFLIP death effector domain assembly
Deposited 2024-03-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 11
PDB declaration: undecameric
|
Chain A
1–479(479 aa)
Chain B
1–479(479 aa)
Chain C
1–479(479 aa)
|
Mutation:F122G, L123G, C360A, D374A, D384A
Mutation:F122G, L123G, C360A, D374A, D384A
Mutation:F122G, L123G, C360A, D374A, D384A
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.49 Å
|
|
8YNN
Structure of the Caspase-8/cFLIP death effector domain assembly
Deposited 2024-03-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain A
1–479(479 aa)
Chain B
1–479(479 aa)
Chain C
1–479(479 aa)
|
Mutation:F122G, L123G, C360A, D374A, D384A
Mutation:F122G, L123G, C360A, D374A, D384A
Mutation:F122G, L123G, C360A, D374A, D384A
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.97 Å
|